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Epigenetic Spreading of the Drosophila Dosage
Compensation Complex from roX RNA Genes
into Flanking Chromatin
the observation that the MSL complex is required for
increased acetylation of histone H4 along the male X
(Turner et al., 1992; Bone et al., 1994; Hilfiker et al.,
1997). Increases in histone H4 acetylation have been
associated with increased transcription in several sys-
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The MSL complex is unlikely to act on every geneBaylor College of Medicine
Houston, Texas 77030 along the X chromosome. Genes such as Lsp-1a, which
has homologs on the autosomes, or the female-specific
yolk protein genes are not dosage compensated (Rob-
erts and Evans-Roberts, 1979; Ota et al., 1981). BothSummary
the X and Y chromosomes carry similar clusters of large
ribosomal RNA genes that are not dosage compensatedThe multisubunit MSL dosage compensation complex
because no dosage difference exists (Ritossa et al.,binds to hundreds of sites along the Drosophila single
1966). Genes, such as runt, may be dosage compen-male X chromosome, mediating its hypertranscription.
sated posttranscriptionally by the SXL protein in femalesThe male X chromosome is also coated with noncod-
(Gergen, 1987; Kelley et al., 1995). Interspersed amonging roX RNAs. When either msl3, mle, or mof is mutant,
these are the bulk of the genes on the X chromosomea partial MSL complex is bound at only z35 unusual
that are postulated to be dosage compensated by thesites distributed along the X. We show that two of
MSL complex in males. The 2-fold upregulation must bethese sites are the roX1 and roX2 genes and postulate
superimposed on the gene-specific transcription factorsthat one of their functions is to provide entry sites for
that control the amount, time, and tissue of expression.the MSL complex to recognize the X chromosome.
This interspersed arrangement of target genes requiresThe roX1 gene provides a nucleation site for extensive
that the MSL complex act over a local area ratherspreading of the MSL complex into flanking chromatin
than a whole chromosome. The properties of cis-actingeven when moved to an autosome. The spreading can
elements that direct the MSL complex to the properoccur in cis or in trans between paired homologs. We
X-linked genes are not understood. One reason the cis-present a model for how the dosage compensation
acting targets of the MSL proteins have been difficultcomplex recognizes X chromatin.
to study is because individual X-derived genes tested so
far do not retain MSL binding when moved to autosomesIntroduction
(Bone, 1996; Bhadra et al., 1999).
Two distinct classes of MSL targets have been pro-Male fruit flies have only one X chromosome, while fe-
posed. Most sites (hundreds) are bound only by com-males have two, and yet both sexes require the same
plete MSL complexes and are thought to mediate theamount of gene products encoded by the X. To over-
2-fold hypertranscription needed for dosage compensa-come the difference in chromosome number, flies rely
tion. A much smaller subset of sites (z30±40) is able toon at least two pathways of dosage compensation to
retain incomplete MSL complexes in cases where oneequalize the final amount of X-encoded gene products
subunit has been removed by mutation (Palmer et al.,(reviewed in Kelley and Kuroda, 1995; Cline and Meyer,
1994; Gorman et al., 1995; Lyman et al., 1997; Gu et al.,1996). The better understood pathway of dosage com-
1998). We have referred to this second class as ªhigh-pensation uses at least five proteins collectively called
affinity MSL sites,º but the nature of these targets is notthe male-specific lethals (MSL; encoded by the msl1,
known. They have been postulated to serve as assemblymsl2, msl3, mle, and mof genes) (reviewed in Lucchesi,
sites of the MSL complex and might provide the best1998). These proteins are found at hundreds of sites
opportunity to define the MSL consensus binding sitealong the male X chromosome. Loss of any one MSL
(Lyman et al., 1997). In this report we will present evi-subunit through mutation prevents the remaining pro-
dence that these unusual sites provide the recognitionteins from binding most or all sites on the X, resulting
mechanism by which the X is distinguished from thein failure to dosage compensate and the death of males.
autosomes and will refer to them here as ªchromatinOne model postulates that the MSL proteins act indi-
entry sites.ºrectly to partition other regulatory proteins between the
The roX RNAs (RNA on X chromosome) are a newX and autosomes (Bhadra et al., 1999). An earlier model
class of noncoding RNAs with the remarkable propertyproposes that the MSL proteins directly mediate the
of coating only the male X chromosome (Amrein andhypertranscription of most genes on the male X chromo-
Axel, 1997; Meller et al., 1997; V. H. M., unpublishedsome (Belote and Lucchesi, 1980; reviewed in Cline and
data). Moreover, the MSL proteins control the accumula-Meyer, 1996). This long-standing model is supported by
tion and X binding of the roX RNAs, suggesting that
these novel RNAs may be additional components of an§ To whom correspondence should be addressed (e-mail: mkuroda@
MSL complex. The finding that dosage compensationbcm.tmc.edu).
in flies may utilize noncoding RNAs prompts comparison‖ Present address: Department of Biology, Tufts University, Medford,
Massachusetts 02155. to dosage compensation in mammals, where the large
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Figure 1. roX1 Gene Structure
(A) The top line shows the organization of
opt1 and roX1 at 3F (Roman et al., 1998).
roX1ex6 is a 1.4 kb deletion generated by im-
precise excision of the P element in roX1MB710.
[GMroX1] contains 4.9 kb of genomic DNA in
pCaSpeR.
(B) Northern analysis of adult poly(A)1 RNA.
Wild-type male (lane 1) and female (lane 2),
and roX1ex6 male (lane 3) and female (lane 4)
hybridized to probes for roX1 and rp49 as a
loading control.
Xist RNA coats the inactive X chromosome in females not required for MSL binding (Figures 2E and 2F). This
(reviewed in Lee and Jaenisch, 1997). issue was further tested with roX2 cDNA transgenes
In this report we show that two of the z30±40 chroma- lacking a flanking promoter. We found that both com-
tin entry sites correspond to the roX1 and roX2 genes. plete and partial MSL complexes bind to a promoterless
We postulate that genes for additional roX RNAs may roX2 cDNA, indicating that the MSL proteins probably
be found at some, but not necessarily all, of the other recognize exonic DNA (Figures 2G and 2H). However,
sites. The MSL proteins bind to roX genes in vivo even we have not excluded the possibility that low levels of
when moved from their normal location on the X chromo- readthrough roX2 transcription may occur from promot-
some and inserted onto the autosomes. The roX1 gene ers in flanking chromatin, or that roX2 may have an
has the unusual property of recruiting the MSL complex unusual internal promoter. Also, these results do not
to the chromosome, where it then spreads long dis- preclude the possibility that MSL proteins bind nascent
tances into flanking genes. This supports a novel mech- roX RNA in addition to roX DNA.
anism for how the MSL complex recognizes its targets. Chromatin entry sites are visualized as the few posi-
tions where partial MSL complexes remain bound to the
Results X when MSL3 is lost through mutation (Figure 2B). We
crossed the roX transgenes into an msl3 mutant back-
roX Genes Are Chromatin Entry Sites ground and stained the polytene chromosomes with
The five individual MSL proteins can be placed into two anti-MSL1 antibodies. This revealed the typical pattern
groups. MSL1 and MSL2 seem to form the core of the of z30±40 chromatin entry sites along the X chromo-
complex because removing either protein through muta- some, with the addition of a new autosomal band at the
tion results in total failure of surviving MSL proteins to site of transgene insertion (Figures 2D, 2F, and 2H). This
bind any site on the X chromosome (Gorman et al., 1993, demonstrates that roX1 and roX2 are sufficient to form
1995; Palmer et al., 1994; Lyman et al., 1997). The MSL3, the 3F and 10C chromatin entry sites, respectively, even
MLE, and MOF proteins may be more peripheral be-
when removed from the environment of the X chro-
cause if one is removed, the surviving subunits form
mosome.partial complexes that remain bound to z35 chromatin
We asked whether MSL binding to the 3F site dependsentry sites on the X chromosome (Palmer et al., 1994;
upon synthesis of wild-type roX1 RNA. The roX1ex6 muta-Gorman et al., 1995; Lyman et al., 1997; Gu et al., 1998).
tion removes the 59 half of the roX1 gene and producesThe nature of these unusual sites has been unclear, but
no stable RNA when assayed by Northern or in situwe noticed that roX1 maps to the chromatin entry site
hybridization (Figure 1 and data not shown). The 3Fat polytene band 3F and roX2 is located at another
chromatin entry band stained with MSL1 antibodieschromatin entry site at 10C (Zhang et al., 1990; Amrein
when either a wild-type allele or the ex6 deletion of roX1and Axel, 1997; Meller et al., 1997).
was present (Figures 2I and 2J). Thus, production ofTo test whether the roX1 and roX2 genes correspond
authentic roX1 RNA is not needed to recruit MSL pro-to the 3F and 10C chromatin entry sites, we constructed
teins to 3F. Either there are multiple MSL targets neartransgenic animals carrying either a genomic fragment
the roX1 gene, or the target lies outside the 1.4 kb regionof roX1 or a roX2 cDNA inserted on an autosome (Figure
deleted in roX1ex6.1). Both transgenes provided excellent MSL targets in
wild-type males (Figures 2C and 2E). To eliminate the
possibility that the MSL proteins were actually binding
The MSL Complex Spreads from roX1the X-derived mini white marker located on the transpo-
into Autosomal Chromatinson, we repeated the analysis with a roX1 cDNA in a
MSL proteins bound the roX1 transgene at all 23 inser-vector marked with the autosomal ry1 gene, and it also
tions sites examined (Table 1). We noticed many linesbound MSL proteins (data not shown). Thus, the roX
displayed multiple bands of MSL staining flanking thegenes are the first defined targets of the MSL complex
roX1 transgene (Figure 3). The frequency of spreadingin vivo. The initial roX2 constructs carried an hsp70 pro-
was highly variable, with most nuclei showing only amoter to drive transcription upon heat shock. MSL pro-
single sharp MSL band at the roX1 transgene (Table 1).teins bound the transgene even without heat shock in-
duction, suggesting that high levels of transcription were The extent of spreading varied from one nucleus to the
Spreading of Dosage Compensation Complexes
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Table 1. MSL Spreading from roX1 Autosomal Transgenes
Percentage of
Transgenic Linea Viability MSL Spreading (n)b
GMroX1-21E V
GMroX1-56D L
GMroX1-57E V 40 (96)
GMroX1-64A L 2 (196)
GMroX1-66C V
GMroX1-66E L 0 (174)c
GMroX1-67B V 6 (298)
GMroX1-79B L 12 (417)
GMroX1-82B V 95 (317)
GMroX1-82C L 0 (322)c
GMroX1-84C L
GMroX1-85D V 27 (385)
GMroX1-87C L 2 (44)
GMroX1-87D V
GMroX1-90E L 5 (150)
GMroX1-91C:57E L Yes, % ND
GMroX1-93B L
GMroX1-94B L 18 (131)
GMroX1-95D V 41 (290)
GMroX1-98A V 28 (142)
GMroX1-98C V 3 (121)
GMroX1-98F V
GMroX1-99C V
Each transgenic line carries a single copy of the genomic roX1
construct, [w1 GMroX1], with the last number and letter indicating
the insertion site on the polytene map. The host genotype is y w
roX1ex6. In each case the MSL proteins bound strongly to the
transgene. In a subset of cases, precise counts of nuclei were made
to determine the frequency of MSL spreading into flanking chro-
matin.
V, viable; L, lethal.
aThe insertions at 21E, 57E, and 98C were generated by standard
P element transformation. All other lines were produced by mobiliz-
ing the 57E insertion with P transposase using genetic crosses. Line
91C carries a translocation between the original 57E insertion site
on the second chromosome and 91C on the third.
bPolytene chromosomes from homozygous transgenic males were
fixed, spread, and stained with antibodies to MSL1. If the insertion
caused a recessive lethal mutation, hemizygous GMroX1/1 or
GMroX1/TM3 males were examined. The first number indicates the
percentage of nuclei showing at least one additional MSL band
spreading into autosomal chromatin. The number of nuclei scored
is given in parentheses. Nuclei were not scored if the chromosomes
failed to spread or were badly broken and separated.Figure 2. roX Genes Are MSL Chromatin Entry Sites
cThe transgenes located at 64A and 82C often showed weak MSL
(A) MSL1 staining pattern of wild-type male X chromosome (red). staining, and in z10%±20% of nuclei, no MSL protein could be
DNA is indicated in blue in all panels. detected at the transgene.
(B) MSL1 staining pattern of w; msl3/msl3 [w1H83M2-6I] paired
female X chromosomes showing the chromatin entry sites. The loca-
tion of roX1 at 3F is indicated by an arrow, and roX2 at 10C is
indicated by an arrowhead. Male larvae mutant for msl3 are difficult next within a single animal (Figure 3). Some insertion
to recover before they die, so all analysis of msl3 mutants was sites such as 82C did not support spreading, while
done in females that carry the H83M2 transgene which ectopically others like 82B were more permissive for spreading,
expresses MSL2 in both sexes (Kelley et al., 1995). Such females
suggesting that the immediate environment strongly af-have the same incomplete set of MSL proteins as a msl3 male
fects the ability of the MSL complex to exit the roX1would have, but they suffer no ill effects and have excellent polytene
gene. Alternatively, individual cells with extensive MSLchromosomes.
(C) Transgenic w/Y; [w1GMroX1-85D] male. MSL proteins bind to spreading may be selected against during development
the roX1 transgene when moved to an autosome (arrow).
(D) Transgenic w; msl3 [w1GMroX1-85D]/msl3 [w1H83M2±6I] fe-
male. Incomplete MSL complex binds to the roX1 transgene indi-
cated by the arrow. (H) Transgenic w; [w1roX2Dpro-48B] ]/1; msl3/msl3 [w1H83M2±6I]
(E) Transgenic w/Y; [w1H70roX2-25A] male. MSL1 binds the autoso- female.
mal roX2 transgene (arrowhead). (I) Detailed view of distal tip of the X chromosome showing MSL1
(F) Transgenic w; [w1H70roX2-25A]/1; msl3/msl3 [w1H83M2-6I] fe- staining at chromatin entry sites. The wild-type roX1 gene is located
male. MSL1 binds in a partial complex to the autosomal roX2 at 3F (arrow).
transgene (arrowhead). (J) The same region as in (G) from y w roX1ex6; msl3/msl3 [w1H83M2-
(G) Transgenic w/Y; [w1roX2Dpro-48B] male. MSL1 binds a promot- 6I] female showing that the 3F chromatin entry site is not removed
erless roX2 transgene (arrowhead). by the ex6 deletion.
Cell
516
Figure 3. MSL Complex Spreads from Autosomal roX1 Transgenes
In all panels, DNA is shown in blue and antibody staining to MSL1 is shown in red.
(A±C) y w roX1ex6/Y; [w1GMroX1-85D] male showing no (A), moderate (B), or extensive (C) spreading from the transgene (arrow). In (C) the
MSL complex covers polytene region 85 and 86A.
(D±F) y w roX1ex6/Y; [w1GMroX1-79B]/1 males showing no (D), moderate (E), and extensive (F) spreading of MSL complex into autosomal
chromatin from the transgene (arrow). In (F) the MSL complex covers polytene regions 77A±79D.
(G±I) Spreading of MSL complex from transgenes located at 98A (G), 91C (H), and 57E (I). In (H) distant spreading of the MSL complex is
indicated by arrowheads.
so that most surviving cells show little spreading (see complex could be observed spreading exclusively
in cis along the transgenic homolog in some nuclei ofbelow). Individual polytene bands can contain .100 kb
of DNA, so MSL binding to several flanking bands means animals hemizygous for the transgene (Figure 4C). How-
ever, hemizygous animals also showed MSL stainingthat the MSL complex was able to spread hundreds
of kilobases into autosomal chromatin. In exceptional across the full width of the paired polytene homologs
in many nuclei (Figures 3D±3F). This could be due tocases, MSL spreading extended over an estimated 1
Mb of autosomal sequence (Figures 3C, 3F, 4D, and 4E). spreading in trans to the nontransgenic homolog or an
illusion caused by wrapping of the two homologs (Fig-Spreading was bidirectional, but not contiguous. MSL-
bound regions were sometimes separated by substan- ure 4A).
To assay for trans spreading, we examined animalstial MSL-negative intervals so that the affected regions
exhibited a distinctly banded appearance (Figure 3). The where homolog pairing had been partially disrupted by
multiply inverted balancer chromosomes. We observedMSL complex was most often found at chromosome
interbands thought to be the sites of actively transcribed several examples of spreading in trans from a roX1
transgene to the nontransgenic balancer chromosomegenes much like the wild-type pattern on the X chromo-
some (Bone et al., 1994). Vigorously transcribed puffed (Figure 4F). This was observed in cases where the region
near the transgene remained synapsed with the invertedregions were particularly good targets. We have called
these z35 unusual sites seen in msl3 mutants ªchroma- homolog. The more common MSL spreading pattern is
illustrated in Figures 4D and 4E. Here the chromosometin entryº sites to reflect this novel activity demonstrated
by the first characterized member, roX1. region surrounding the roX1 transgene was not paired
with the inverted homolog, and the only autosomal seg-We examined the pattern of MSL spreading along
the autosomes to see whether it occurred exclusively ment of the genome staining with MSL1 surrounded the
transgene. No staining was detectable on the invertedin cis. The maternal and paternal homologs are tightly
synapsed along their entire length in polytene chromo- homolog. We conclude that the MSL complex spreads
predominantly in cis, but the complex can spread to asomes (Figure 4A). When males homozygous for a
particular transgene were examined, we often observed paired homolog in trans. Of course, in wild-type males
the single X has no homolog with which to pair.more spreading along one homolog than the other.
This was evident as MSL bands extending only half the The MSL complex that spreads into autosomal se-
quences from a roX1 transgene contains a full set ofwidth of the paired chromosome (Figure 4B). The MSL
Spreading of Dosage Compensation Complexes
517
subunits (data not shown). This may elevate gene ex-
pression in the region surrounding the roX1 transgene,
but the variable mosaic nature of spreading makes it
unlikely that enough cells would suffer inappropriate
dosage compensation to measure this increase in whole
animals. We instead used histone H4 acetylation as a
surrogate marker for hypertranscription of the autoso-
mal genes surrounding the roX1 transgene. The MOF
acetyltransferase thought to carry out the acetylation of
histone H4 spreads with the MSL complex (Hilfiker et
al., 1997) (Figure 5C). Spreading of the MSL complex
resulted in acetylation of H4 on Lysine 16 in the local
region surrounding the roX1 transgene (Figure 5B ), sug-
gesting that the autosomal genes near roX1 acquire
dosage compensation.
Both roX2 and roX1 RNAs Spread
from roX1 Transgenes
roX1 RNAs are precisely colocalized with the MSL pro-
teins along the X chromosome (Meller et al., 1997;
V. H. M. et al., unpublished data). We used RNA in situ
hybridization to polytene chromosomes to test whether
roX1 RNA spreads along with the MSL proteins into
autosomal chromatin. In males carrying an X chromo-
some with the null roX1ex6 mutation, the autosomally
encoded roX1 RNA coats the entire X in a wild-type
banding pattern, confirming earlier work showing that
roX1 RNA can act in trans (Meller et al., 1997) (Figure
6A). More importantly, in some nuclei roX1 RNA spreads
from the autosomal transgene in a pattern similar to that
seen for the MSL proteins (Figures 6B and 6C). This
shows that roX1 RNA is able to bind not only X chroma-
tin, but also sites on autosomes. The hybridization signal
was often noticeably brighter surrounding the autoso-
mal transgene than on the X (Figure 6C). This is consis-
tent with the observation that roX1 RNA is most abun-
dant surrounding its site of synthesis (V. H. M. et al.,
unpublished data).
We next asked whether roX2 RNA could access and
spread on an autosome if provided with a roX1 chroma-
tin entry site in trans. This was tested by repeating the
RNA in situ hybridizations using a roX2 probe. Figure
6D shows a male in which the X-encoded roX2 RNA
spreads from an autosomal roX1 transgene. We con-
clude that roX RNAs can bind and spread from multiple
Figure 4. Spreading in Both cis and trans chromatin entry sites and are not limited to the site of
(A) Diagram showing that maternal (m) and paternal (p) homologs their own transcription.
are tightly synapsed in wild-type polytene chromosomes. A band
that covers the entire width of the pair may be coming from both Discussion
homologs (a) or just one (b). A signal coming from only one homolog
will sometimes appear as a half-width band (c).
A Model for the X Chromosome Specificity(B) Unequal spreading of MSL1 from each transgene in a male
homozygous for [w1GMroX1-57E] (arrow). Insert shows the MSL1 of Dosage Compensation
signal alone with the half-width bands indicated by arrowheads. Our studies suggest a two-step process for recognition
(C) y w roX1ex6; [w1GMroX1-82B]/TM3, Sb e male displaying MSL1 of the X chromosome by the MSL complex (Figure 7).
spreading exclusively in cis from the transgene (arrow). An inversion In the first step, MSL1 and MSL2 together recognize
in the TM3 balancer disrupts pairing distal to the transgene.
30±40 sites distributed along the length of the X where(D) y w roX1ex6/Y; [w1GMroX1-79B]/TM3, Sb e male in which the
region surrounding the transgene (arrow) cannot pair with the bal-
ancer chromosome. Although MSL1 spreads extensively in cis, no
staining is evident on the TM3 homolog. The X chromosome is out
of the field. (F) y w roX1ex6/Y; [w1GMroX1-94B]/TM3, Sb e male in which an
(E) y w roX1ex6/Y; [w1GMroX1-94B]/TM3, Sb e male in which exten- inversion disrupts pairing between the homologs near the transgene
sive MSL1 spreading occurs in cis from the unpaired transgene (arrow). MSL staining is evident on both homologs. The inset shows
(arrow), but not on the TM3 homolog. The X chromosome is also the MSL1 signal alone with the MSL complex on the nontransgenic
visible at right. inverted chromosome indicated by the arrowhead.
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Figure 5. Acetylation of Histone H4 Surrounding roX1 Transgenes
(A and B) Third chromosome from y w roX1ex6/Y; [w1GMroX1-82B]/
TM3, Sb e male stained with antibodies to MSL1 (A) and H4Ac16
(B), both red. Arrow indicates location of the transgene. The 82B
transgene is located very near the centromere, and the chromosome
is frequently stretched or broken at that point.
(C) Chromosomes from y w roX1ex6/Y; [w1GMroX1-85D] male stained
with antibodies to the MOF acetyltransferase (red). The X chromo-
some crosses the center of the field.
Figure 6. roX1 and roX2 RNAs Spread from Autosomal roX1
Transgenes
(A and B) y w roX1ex6/Y; [w1GMroX1-85D] males hybridized withthey recruit the other MSL proteins. We show here that
digoxygenin-labeled riboprobes (red). Arrow indicates the location
at least two of these sites encode roX RNAs and suggest of the transgene. In (A) no spreading from the transgene is evident,
that these RNAs are incorporated into the growing MSL but the roX1 RNA synthesized from the transgene coats the X chro-
complex. In the second step, the MSL complex can mosome in trans. In (B) the X chromosome is out of the field, but
roX1 RNA can be seen to spread to sites distant from the transgene.associate with chromatin entry sites on the X and then
(C and D) y w roX1ex6/Y; [w1GMroX1-82B]/TM3, Sb e males hybrid-spread along the chromosome in cis to locate all of the
ized with roX1 (C) or roX2 (D) antisense riboprobes (red). In (C)genes that utilize MSL-mediated dosage compensation.
the roX1 hybridization signal is stronger surrounding the autosomal
Our results call into question a long-standing assump- transgene (arrow) than on the X chromosome. In (D) a portion of the
tion that X chromosome±specific cis-acting sequences X is visible (lower right).
will be associated with most genes bound by the MSL
proteins. Rather, we find that when the MSL complex attributed to the lack of nearby roX genes (Gutierrez et
is attracted to an autosome by a roX1 transgene, it can al., 1989; Cooper et al., 1994; Qian and Pirrotta, 1995).
spread in cis to genes that were never before dosage Previous attempts to detect MSL binding at transgenes
compensated. Thus, the MSL complex may be attracted containing the yellow, white, salivary gland secretion 4,
in cis to sequences or proteins that are common to many or phosphogluconate dehydrogenase genes moved to
active genes throughout the genome. The MSL complex autosomes have all failed (Bone, 1996; Bhadra et al.,
cannot gain access to the autosomes in wild-type males 1999). In striking contrast, we find that two chromatin
because the MSL chromatin entry sites are found only entry sites, the roX1 and roX2 genes, provide strong
on the X. sites of MSL binding independent of linkage to the X
Our model for assembly and spreading of MSL com- chromosome.
plexes on the X chromosome could explain how some If 2 of z35 chromatin entry sites are roX genes, do
autosomal genes acquire dosage compensation when any of the uncharacterized sites express novel noncod-
moved to the X (Scholnick et al., 1983; Spradling and ing roX RNAs? We note that 3F and 10C are among the
Rubin, 1983). Conversely, once removed from the X brightest sites seen in msl3 mutants, so the weaker
chromosome environment and roX genes, it may be ones may differ qualitatively. We have not determined
difficult for isolated genes imbedded in autosomal chro- whether synthesis of roX1 RNA at the transgene is nec-
matin to interact with the MSL proteins. Others have essary for MSL spreading. Finding that MSLs bind an
reported only partial dosage compensation of isolated apparently nontranscribed roX2 cDNA transgene sug-
gests that not all chromatin entry sites are necessarilyX-derived genes moved to autosomes, which might be
Spreading of Dosage Compensation Complexes
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et al., 1996). Although this may have occurred by each
gene independently mutating flanking sequence to cre-
ate a new MSL-binding site, our model suggests that
an early event in this process could have been the arrival
of one or more chromatin entry sites onto the neo X.
This would allow MSL spreading to new targets without
the necessity of creating new cis-acting sequences for
each gene. In fact, some of the autosomal MSL staining
patterns we show here are similar to the MSL staining
pattern reported for the miranda neo X (Figure 3H).
When the roX1 gene is inserted into autosomal chro-
matin, the MSL complex spreads in a much more vari-
able pattern compared to the X. This may indicate that an
important process in the evolution of the X chromosome
was the acquisition of sequences which facilitate MSL
spreading. The X chromosome contains many copies
of simple dinucleotide repeats such as (dC-dA)n´(dG-
dT)n that are less abundant on the autosomes (Pardue
et al., 1987; Lowenhaupt et al., 1989). Longer repeat
elements have also been found preferentially enrichedFigure 7. Model for MSL Binding to Chromatin
on the X (Waring and Pollack, 1987; DiBartolomeis et(A) The MSL subunits enter the nucleus and begin assembly at 30±40
al., 1992). Perhaps one of these repeat families promoteschromatin entry sites along the X chromosome, two of which are
known roX genes. The proteins may form incomplete complexes reliable spreading of the MSL complex. Fewer copies of
with nascent roX RNA at this point. these repeats on the autosomes may impede spreading
(B) Complexes travel between chromatin entry sites so that roX2 from the roX1 transgenes. A somewhat similar model
RNA is found at the roX1 gene. At this point roX1 RNA from an has been put forward postulating that the presence of
autosomal transgene could locate the X. Conversely, roX2 RNA
abundant LINE elements along the mammalian X chro-made on the X could bind a roX1 transgene on an autosome.
mosome may aid spreading of Xist RNA (Boyle et al.,(C) Upon maturation of the complex, it is competent to spread in
1990; Lyon, 1998). A second explanation for the ineffi-cis along the chromosome until locating a suitable target gene where
it modifies chromatin structure. cient spreading that we observe on autosomes is that
(D) A wild-type male X chromosome with MSL complex found at our genetic strategy for producing transgenic lines de-
several dozen chromatin entry sites and several hundred ordinary manded that all insertions be male viable. This may have
target genes.
biased the populations of insertion sites sampled to
exclude any sites where MSL complex would efficiently
spread and cause deleterious dosage compensation oftranscribed. If additional roX genes exist, they may not
linked autosomal genes.
resemble either roX1 or roX2, because each encodes
Our model provides a framework to begin testing the
an RNA of very different size (3.5 kb versus 1.2 kb)
mechanism of MSL action, but it cannot account for all
sharing no obvious primary sequence similarity (Amrein
observations. For instance, although the male au-
and Axel, 1997). tosomes are almost entirely devoid of MSL proteins, we
Our results suggest that some MSL proteins bind to regularly observe at least four endogenous MSL-binding
the roX transgenes through exonic DNA. However, we sites of variable intensity (located at 21B, 30B, 56A, and
cannot exclude the possibility that some MSL proteins 91D). The identities of these sites are unknown, but
may also contact nascent roX transcripts. There are two they show that the MSL complex can bind rare, isolated
lines of evidence that roX RNAs are incorporated into autosomal sites unlinked to any known roX gene. In
MSL complexes, perhaps cotranscriptionally. First, ec- addition, several large fragments of X chromatin (z200±
topically expressed roX RNAs are highly unstable in the 700 kb) duplicated onto the autosomes show MSL bind-
absence of MSL complex and accumulate in females ing (Bone, 1996; Bhadra et al., 1999). Some of these
only if MSL complex is coexpressed. Second, both roX fragments are reported to span intervals lacking a
RNAs and MSL proteins precisely colocalize on the male mapped chromatin entry site, and yet the MSL complex
X chromosome (V. H. M. et al., unpublished data). is able to bind the segment of relocated X chromatin.
The most difficult issue is that some X-derived transgenes
The Evolution of MSL-Binding Sites are reported to retain partial dosage compensation
Evolutionary studies of various Drosophila species have when moved to autosomes (Gutierrez et al., 1989; Coo-
suggested that dosage compensation can be acquired per et al., 1994; Qian and Pirrotta, 1995). In the case
relatively rapidly as sex chromosome karyotypes evolve of white, a commonly used reporter gene, the level of
(Charlesworth, 1996). The most striking example is seen dosage compensation can be improved if the transgene
in Drosophila miranda, in which a former autosome has is surrounded with su(Hw) chromatin insulator elements
translocated onto the Y chromosome where its genes (Roseman et al., 1995). One possible explanation for
are in the process of degenerating. The surviving arm, these observations is based on the ability of the MSL
now the neo X, is in the process of acquiring MSL- complex to spread to a paired homolog in trans. Al-
mediated dosage compensation as seen by new MSL though the single male X normally has no pairing partner,
and H4Ac16 bands, both clustered and widely spaced perhaps X duplications can efficiently receive MSL com-
plex in trans if they are large enough to pair well with(Bone and Kuroda, 1996; Marin et al., 1996; Steinemann
Cell
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the homologous region of the X. Single transgenes chromosomes, a defined initiation site for spreading,
and the availability of mutants in the protein and RNAwould have more difficulty pairing with the X and so
would display only partial dosage compensation. spreading components make the MSL complex an ideal
model system to determine how changes in chromatin
architecture affect gene expression in complex organisms.Parallels between roX and Xist
Both flies and mammals face the same problem of equal-
Experimental Proceduresizing gene expression from two X chromosomes in fe-
males and one in males. Female mammals inactivate
Transgenicsmost of the genes on one X chromosome in each cell
The roX1 genomic transgene was made from a 4.9 kb EcoRI frag-
to form the Barr body (reviewed in Lee and Jaenisch, ment containing all of roX1 and the 39 end of opt1 inserted into
1997). Female flies actively transcribe both X chromo- pCaSpeR. The roX1 cDNA c3 was a nearly full-length 3.2 kb KpnI/
XbaI fragment inserted into pPBret (Roman et al., 1999). The roX2.13somes, and the male is forced to hypertranscribe his
cDNA (Amrein and Axel, 1997) was cloned into both pCaSpeR (inser-single X (reviewed in Cline and Meyer, 1996). These
tions at 22E, 48B, and 60B10 tested) and pCaSpeR-hs (insert at 25A)apparently unrelated mechanisms both utilize noncod-
(Pirrotta, 1988). The presence or absence of the Hsp70 promoter hading, spliced, polyadenylated RNA to coat the dosage-
no effect on MSL binding in either wild-type or msl3 backgrounds.
compensated chromosome; Xist in the case of mammals Transgenics were produced using P element±mediated transforma-
and roX RNAs in flies (Brown et al., 1992; Clemson et tion (Spradling and Rubin, 1982). Three original lines were isolated
carrying GMroX1 at 21E, 57E, and 98A. GMroX1-57E was remobil-al., 1996; Meller et al., 1997). The locations of the genes
ized by genomic P transposase (Robertson et al., 1988), and addi-encoding these unusual RNAs mark the chromosome
tional hops to the third chromosome were recovered.that is the target of regulation, the X chromosome. Xist
is associated with hypoacetylated histones and global
Northern Analysis
inactivation, while roX is associated with a specific ace- RNA was prepared as described in Kelley (1993), separated on 1%
tylated form of histone H4 and elevated gene expression agarose gels containing formaldehyde, and transferred to Hybond
(Turner et al., 1992; Jeppesen and Turner, 1993). N1 membrane in 50 mM NaOH. Probes were made by random prim-
ing plasmids containing roX1 cDNA20 (Meller et al., 1997).One of the most striking differences between Xist and
roX RNAs is that the mammalian Xist must not only
Polytene Stainingdistinguish between the autosomes and the X, but must
Transgenic larvae were grown at 188C in uncrowded vials on stan-choose one of the female X chromosomes for inactiva-
dard cornmeal molasses food. Larvae were dissected in PBS, 4%
tion and spare the other. This second requirement may formaldehyde, 1% Triton X100, and fixed 45 s (anti-MSL) or 5 min
explain why Xist RNA acts exclusively in cis so that the (anti-H4Ac16). The fixative was replaced with 50% acetic acid, 4%
active X is protected. That the Drosophila MSL proteins formaldehyde for 2 min and then the glands were placed in lactoace-
tic acid (lactic acid:water:acetic acid, 1:2:3) and spread under aand roX RNAs do not face the same problem may ac-
siliconized coverslip. The slides were blocked with 0.2% BSA 1 5%count for the ability of roX RNAs to enter the Drosophila
horse serum in PBT and either treated with affinity-purified rabbitX chromosome at numerous points in trans (Meller et
anti-MSL1, anti-MOF (both used 1:50 dilution), anti-H4Ac16 (Sero-
al., 1997). This mechanistic difference means that Xist tec, 1:200 dilution) or processed for RNA in situ hybridization to
must spread from a single origin, the Xic, to cover most single-stranded roX riboprobes (V. H. M. et al., unpublished data).
of the 155 Mb of the X (human) (reviewed in Lee and
Jaenisch, 1997). By contrast, flies appear to utilize z35 Acknowledgments
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Note Added in Proof
While this paper was in press, A. Franke and B.S. Baker reported
the detection of a 30 nt segment of primary sequence similarity
between roX1 and roX2: A. Franke and B.S. Baker (1999). The rox1
and rox2 RNAs are essential components of the compensasome,
which mediates dosage compensation in Drosophila. Mol. Cell 4,
117±122.
